MedPath

Feasibility of High Intensity Interval Training in Knee Osteoarthritis

Not Applicable
Completed
Conditions
Knee Osteoarthritis
Interventions
Behavioral: High intensity interval training (HIIT)
Registration Number
NCT03281668
Lead Sponsor
University of North Carolina, Chapel Hill
Brief Summary

The focus of this pilot study is to evaluate the feasibility of utilizing an evidenced-based high intensity interval training program (HIIT) to improve physical function in patients with knee osteoarthritis (OA).

Detailed Description

All participants will be assigned to the single-arm of the study in which all participants will receive 12 weeks of HIIT, delivered twice per week. The primary outcome will examine the feasibility and acceptability of the 12 week HIIT program in patients with knee OA symptoms ranging from mild to severe. The investigators will determine adherence to and tolerability of HIIT, acceptability, and recruitment and retention rates during the 12 week program. Additional outcomes will include physical function, knee OA symptomatic burden (pain), static standing balance, isometric knee extensor and flexor strength, cardiorespiratory fitness, and body composition.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
29
Inclusion Criteria
  • between the ages of 40 and 75 years old
  • body mass index of 18.5-50 kg/m²
  • exhibits symptomatic knee OA, defined as a diagnosis of knee OA, as identified from University of North Carolina electronic medical records, and current knee symptoms in at least one knee, having a minimum score of 6 out of 20 on the Western Ontario and McMasters Universities Osteoarthritis Index (WOMAC) pain subscale.
Exclusion Criteria
  • individuals diagnosed with a cardiovascular condition restricting exercise
  • individuals currently meeting Department of Health and Human Services Guidelines for physical activity (≥ 150 minutes per week
  • individuals currently doing HIIT
  • individuals currently participating in physical therapy for knee OA
  • individuals currently participating in another OA intervention study
  • received a corticosteroid or hyaluronic acid intra-articular injection in the knee during the previous 3 weeks or scheduled for during the intervention
  • diagnosis of gout in the knee
  • diagnosis of rheumatoid arthritis
  • diagnosis of fibromyalgia
  • other systemic rheumatic disease
  • severe dementia or other memory loss
  • active diagnosis of psychosis or uncontrolled substance abuse disorder
  • hospitalization for a stroke, heart attack, or heart failure, or had surgery for blocked arteries in the past 3 months
  • total joint replacement knee surgery, other knee surgery, meniscus tear, or anterior cruciate ligament (ACL) tear in the past 6 months
  • on a waiting list for total joint replacement
  • severely impaired hearing or speech
  • pregnant or planning to become pregnant while enrolled in the study
  • inability to speak English
  • serious or terminal illness as indicated by referral to hospice or palliative care
  • nursing home residence
  • inability to ride a stationary bike
  • any other health problems that would prohibit safe participation in the study
  • EKG results EKG suggesting the individual would not be able to safely participate in this study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
InterventionHigh intensity interval training (HIIT)Intervention consists of High Intensity Interval Training (HIIT) session which is af 3-5 minute warm up, followed by 10 repetitions of 1 minute bouts at individualized training intensity with 1 minute rest periods.
Primary Outcome Measures
NameTimeMethod
Percentage of Enrolled Participants Retained at the End of the StudyStudy completion (12 weeks)

Number of participants who completed the study (baseline through 12 week assessments) divided by the total number of enrolled participants with baseline assessments

Percent of Potential Participants Screened for the Study Who Are EnrolledBaseline

Number of participants screened and enrolled divided by the total number of participants screened

Secondary Outcome Measures
NameTimeMethod
Change in Feet Together StandBaseline, 12 weeks

Feet together stand for up to 10 seconds without assistive device

Change in Semi-tandem StandBaseline, 12 weeks

Heel of one foot placed to the side of the big toe of the other foot, for up to 10 seconds

Change in Tandem StandBaseline, 12 weeks

One foot in front of the other, heel touching toe, for up to 10 seconds

Change in One Leg StandBaseline, 12 weeks

One leg stand for up to 30 seconds

Change in Cardiorespiratory FitnessBaseline, 12 weeks

Measure by peak oxygen consumption (VO2peak),to identify fitness level and evaluate cardiovascular effects. Test will establish individual training intensity.

Change in Whole Body Fat MassBaseline, 12 weeks

fat mass in kilograms, measured with dual energy x-ray absorptiometry (DXA)

Change in Lean Body MassBaseline, 12 weeks

lean body mass in kilograms, measured with DXA

Change in Visceral FatBaseline, 12 weeks

visceral fat in kilograms, measured with DXA

Change in Knee StrengthBaseline, 12 weeks

Humac isokinetic dynamometer to measure isokinetic power and isometric strength of knee flexors extensors

Average Number of Training Sessions Completed Per WeekWeekly measures for 12 consecutive weeks

Up to 2 training sessions were possible each week over the 12 week intervention

Total Number of Training Sessions Completed12 weeks

Total number of training sessions completed out of up to 24 sessions (2 per week over 12 weeks)

Total Number of Training Weeks Completed12 weeks

Total number of training weeks (up to 12 weeks possible)

Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score From Baseline to 12 WeeksBaseline,12 weeks

The WOMAC, a measure of lower extremity pain (5 items), stiffness (2 items), and function (17 items), will be used to measure overall symptomatic burden of knee osteoarthritis (OA). Each item is scored from 0-4 (none, slight, moderate, severe, and extreme). Items are added to calculate a total WOMAC score ranging from 0 (no problems) to 96 (extreme problems). A higher score means a worse outcome.

Change in WOMAC Pain Subscale From Baseline to 12 WeeksBaseline,12 weeks

The WOMAC pain subscale contains 5 items about knee pain. Each item is scored from 0-4 (none, slight, moderate, severe, and extreme). Items are added to calculate a WOMAC pain score ranging from 0 (no pain) to 20 (extreme pain). A higher score means more severe pain.

Change in WOMAC Function Subscale From Baseline to 12 WeeksBaseline, 12 weeks

The WOMAC function subscale contains 17 items about knee function during daily activities. Each item is scored from 0-4 (none, slight, moderate, severe, and extreme). Items are added to calculate a WOMAC pain score ranging from 0 (no problems with function) to 68 (extreme problems with function). A higher score means worse function.

Change in 20m Fast Paced Walk TestBaseline, 12 weeks

Measure of the ability to walk quickly over short distances. Participants walk at fast pace that is timed over 2 x 10m.

Change in Number of Chair Stand Repetitions CompletedBaseline, 12 weeks

Number of chair stand repetitions completed in 30 seconds

Change in Stair Climb TestBaseline, 12 weeks

Time in seconds to ascend and descend a flight of stairs

Change in Timed Up and GoBaseline, 12 weeks

Time in seconds to rise from a chair, walk 3 m, turn, walk back to chair, and sit down

Trial Locations

Locations (1)

University of North Carolina

🇺🇸

Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath